STOCK TITAN
  1. Home
  2. Sec-filings
  3. KRRO
  4. [EFFECT] Korro Bio, Inc. SEC Filing

[EFFECT] Korro Bio, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 20, 2026 4:15 P.M.
Form: S-3
CIK: 0001703647
Company Name: Korro Bio, Inc.
File Number: 333-294298

Source: View Original Filing on SEC EDGAR

Korro Bio, Inc.

NASDAQ:KRRO

View KRRO Stock Overview →

KRRO Rankings

#4744 Ranked by Market Cap
N/A Ranked by Dividends

KRRO Latest News

Mar 12, 2026
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 9, 2026
Korro Announces Oversubscribed $85 Million Private Placement
Feb 25, 2026
Korro to Present at the TD Cowen 46th Annual Health Care Conference
Jan 20, 2026
Korro to Host Virtual Analyst Day on January 27, 2026
Jan 8, 2026
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference

KRRO Latest SEC Filings

Mar 20, 2026
[424B5] Korro Bio, Inc. Prospectus Supplement (Debt Securities)
Mar 17, 2026
[SCHEDULE 13G] Korro Bio, Inc. Passive Investment Disclosure (>5%)
Mar 13, 2026
[S-3] Korro Bio, Inc. Shelf Registration Statement
Mar 12, 2026
[Form 4] Korro Bio, Inc. Insider Trading Activity
Mar 12, 2026
[Form 4] Korro Bio, Inc. Insider Trading Activity

KRRO Stock Data

162.54M
9.20M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE